| Primary |
| Staphylococcal Infection |
28.2% |
| Pneumonia |
10.2% |
| Infection |
7.2% |
| Pneumonia Staphylococcal |
6.9% |
| Sepsis |
6.2% |
| Hypertension |
5.1% |
| Enterococcal Infection |
4.6% |
| Staphylococcal Sepsis |
4.3% |
| Osteomyelitis |
3.2% |
| Ill-defined Disorder |
2.8% |
| Wound Infection Staphylococcal |
2.5% |
| Pain |
2.4% |
| Prophylaxis |
2.4% |
| Urinary Tract Infection |
2.3% |
| Depression |
2.2% |
| Cardiac Failure |
2.1% |
| Cellulitis |
2.1% |
| Diabetes Mellitus |
1.9% |
| Drug Use For Unknown Indication |
1.8% |
| Endocarditis |
1.7% |
|
| Thrombocytopenia |
13.4% |
| Platelet Count Decreased |
12.7% |
| Death |
8.8% |
| Vomiting |
7.3% |
| Hyponatraemia |
6.3% |
| Pancytopenia |
6.1% |
| Serotonin Syndrome |
5.6% |
| White Blood Cell Count Decreased |
4.5% |
| Drug Ineffective |
4.2% |
| Nausea |
4.0% |
| Renal Impairment |
3.7% |
| Rash |
3.2% |
| Diarrhoea |
2.9% |
| Neuropathy Peripheral |
2.9% |
| Renal Failure |
2.6% |
| Renal Failure Acute |
2.5% |
| Lactic Acidosis |
2.4% |
| Drug Interaction |
2.4% |
| Staphylococcal Infection |
2.4% |
| Bone Marrow Failure |
2.3% |
|
| Secondary |
| Staphylococcal Infection |
17.6% |
| Pneumonia |
9.1% |
| Drug Use For Unknown Indication |
8.9% |
| Product Used For Unknown Indication |
7.9% |
| Hypertension |
7.3% |
| Sepsis |
7.1% |
| Pain |
5.3% |
| Infection |
4.4% |
| Pyrexia |
4.4% |
| Prophylaxis |
3.2% |
| Depression |
3.1% |
| Staphylococcal Sepsis |
3.1% |
| Osteomyelitis |
3.0% |
| Pneumonia Staphylococcal |
2.8% |
| Cellulitis |
2.5% |
| Urinary Tract Infection |
2.3% |
| Atrial Fibrillation |
2.0% |
| Intervertebral Discitis |
1.9% |
| Pulmonary Tuberculosis |
1.8% |
| Enterococcal Infection |
1.8% |
|
| Thrombocytopenia |
12.3% |
| Pancytopenia |
10.8% |
| Platelet Count Decreased |
8.4% |
| Vomiting |
7.1% |
| Renal Impairment |
5.8% |
| Serotonin Syndrome |
5.2% |
| Hyponatraemia |
5.0% |
| Death |
4.7% |
| Renal Failure Acute |
4.5% |
| White Blood Cell Count Decreased |
4.2% |
| Sepsis |
3.9% |
| Weight Increased |
3.7% |
| Convulsion |
3.4% |
| Pneumonia |
3.4% |
| Drug Ineffective |
3.1% |
| Staphylococcal Infection |
3.1% |
| Drug Interaction |
2.9% |
| Hepatic Failure |
2.9% |
| White Blood Cell Count Increased |
2.9% |
| Decreased Appetite |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.4% |
| Drug Use For Unknown Indication |
17.3% |
| Sepsis |
4.7% |
| Prophylaxis |
4.4% |
| Unevaluable Event |
3.4% |
| Pneumonia |
3.3% |
| Pain |
3.1% |
| Infection Prophylaxis |
2.9% |
| Infection |
2.8% |
| Multiple Myeloma |
2.8% |
| Acute Myeloid Leukaemia |
2.5% |
| Osteoporosis |
2.4% |
| Rectal Cancer |
2.1% |
| Acute Lymphocytic Leukaemia |
2.0% |
| Hypertension |
1.9% |
| Pyrexia |
1.9% |
| Cardiac Failure |
1.6% |
| Systemic Lupus Erythematosus |
1.6% |
| Febrile Neutropenia |
1.5% |
| Antibiotic Therapy |
1.3% |
|
| Wound Infection Staphylococcal |
11.1% |
| Vomiting |
9.2% |
| Thrombocytopenia |
7.3% |
| White Blood Cell Count Decreased |
7.3% |
| Sepsis |
6.7% |
| Pneumonia |
5.7% |
| Renal Failure Acute |
5.4% |
| Septic Shock |
5.4% |
| Renal Impairment |
4.4% |
| Death |
4.1% |
| Respiratory Failure |
3.8% |
| Staphylococcal Infection |
3.8% |
| Toxic Skin Eruption |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Pyrexia |
3.5% |
| Multi-organ Failure |
3.2% |
| Nausea |
3.2% |
| Visual Impairment |
3.2% |
| Rash |
2.5% |
| Renal Failure |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
23.5% |
| Staphylococcal Infection |
11.3% |
| Depression |
9.9% |
| Product Used For Unknown Indication |
7.6% |
| Pneumonia |
5.3% |
| Hypertension |
5.0% |
| Infection |
4.3% |
| Pain |
3.3% |
| Urinary Tract Infection |
3.3% |
| Juvenile Arthritis |
3.0% |
| Pyrexia |
3.0% |
| Serotonin Syndrome |
3.0% |
| Bacterial Infection |
2.6% |
| Pseudomonas Infection |
2.6% |
| Enterococcal Infection |
2.3% |
| Localised Infection |
2.0% |
| Lung Disorder |
2.0% |
| Mycobacterial Infection |
2.0% |
| Osteomyelitis |
2.0% |
| Tendonitis |
2.0% |
|
| Hypertension |
21.7% |
| Drug Interaction |
12.0% |
| Pyrexia |
12.0% |
| Serotonin Syndrome |
10.8% |
| Hyperthermia Malignant |
6.0% |
| Vomiting |
6.0% |
| Convulsion |
3.6% |
| Pharyngeal Erythema |
3.6% |
| Epilepsy |
2.4% |
| Memory Impairment |
2.4% |
| Red Blood Cell Count Decreased |
2.4% |
| Renal Failure Acute |
2.4% |
| Skin Exfoliation |
2.4% |
| Staphylococcal Sepsis |
2.4% |
| Urinary Tract Infection |
2.4% |
| Visual Impairment |
2.4% |
| Drug Level Decreased |
1.2% |
| Drug Level Fluctuating |
1.2% |
| Haemorrhage |
1.2% |
| Leukopenia |
1.2% |
|
